基本信息
views: 1
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Paul Stockhammer is a third-year internal medicine resident at the Yale School of Medicine. He obtained his MD/PhD degree from the Medical University of Vienna, Austria, where he studied the role of transforming growth factor-ß in pleural mesothelioma and HDAC inhibitors in lung cancer. His current research focuses on EGFR-driven lung cancer and drug resistance, investigating the relationship between EGFR and co-occurring tumor suppressor gene alterations.
Research Interests
Papers共 42 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
BLADDER CANCERno. 1 (2024): 9-23
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)
Lung cancer (Amsterdam, Netherlands) (2023): 107360-107360
Paul Stockhammer, Michael Grant,Anna Wurtz,Giorgia Foggetti,Francisco Expósito,Jianlei Gu,Hongyu Zhao,Jungmin Choi, Sangyun Chung,Fangyong Li,Zenta Walther, Julia Dietz,
Journal of Thoracic Oncologyno. 9 (2022): S462-S463
31. Jahrestagung der Deutschen Gesellschaft für Thoraxchirurgie Zentralblatt für Chirurgie - Zeitschrift für Allgemeine, Viszeral-, Thorax- und Gefäßchirurgie (2022)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn